Talkspace, Inc. Q2 FY2024 earnings call

Management Statement and Operational Highlights

• Market Demand: Survey data shows 85% of people more open to therapy than 5 years ago, supporting business optimism. Gen Z and seniors cite loneliness as top therapy concerns.
• Revenue Growth: Total revenue $46.1 million, up 29% YOY; adjusted EBITDA $1.2 million, second consecutive profitable quarter.
• Payer Initiatives: Expanded covered lives to 145 million, launched Medicare website, added TRICARE with Humana Military, and focused on product improvements (e.g., real-time co-pays), marketing, and partnerships.
• Direct-to-Enterprise: Growth driven by team space programs, successes with schools and employers, and strong pipeline. Introduced self-serve portal for SMBs.
• Provider Network: Over 5,700 therapists, with investments in AI features like secure captions and AI smart notes to enhance therapist efficiency.

Segment Performance

• Payer Revenue: Grew 62% year-over-year to $29.9 million. Covered lives expanded from 131 million to 145 million, with plans to reach all 50 states for Medicare by year-end and new payer contracts expected. Payer sessions completed grew 49% YOY to nearly 299,000.
• Direct-to-Enterprise Revenue: Grew 20% year-over-year to $9.6 million, driven by initiatives like the New York City team space program and strong pipeline in employer and team segments. Sequentially, down 3% due to timing of new contract wins.
• Consumer Revenue: $6.5 million, a 28% YOY decline, aligning with strategy to optimize traffic conversion and segment mix.

Guidance

• Reiterated 2024 guidance: revenue in range of $185 million to $195 million and adjusted EBITDA between $4 million and $8 million.
• Optimistic about payer business growth, Medicare rollout progress, and strong pipeline in direct enterprise.

Risks

• Uncertainties around Medicare utilization and lifetime value (LTV).
• Competitive landscape changes as competitors may enter payer coverage space, impacting market dynamics.
• Execution risks related to rolling out new payer contracts and managing cost structures.

Question and Answer

Q: How should we think about the economics and utilization metrics of government lives (Medicare, TRICARE) compared to commercial?

A: Uncertainties around LTV and reimbursement; rollout plan is deliberate with marketing spigot opened carefully. No data yet on Medicare utilization.

Q: Can you walk through cost optimization buckets and why OpEx is flattening?

A: Cost optimization continues with initiatives to save in G&A and reinvest in revenue-generating areas like new product development and marketing. Flattening not due to Medicare rollout but ongoing cost discipline and optimization.

Q: Thoughts on a competitor entering payer coverage space?

A: Going in-network requires product design, credentialing, operationalization, and quality control, which takes time; Talkspace has a two-and-a-half-year journey in this area.

Q: Timing of Medicare rollout in 50 states and marketing spend impact?

A: On track for 50 states by year-end, with marketing spend planned carefully; no material negative impact on EBITDA expected from rollout.

Q: Demand in the employer channel?

A: Strong interest in employer segment, especially for mental health benefits, with self-serve portal for SMBs showing traction and pipeline strength in employer vertical.